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Abstract 
 
Background: There is a niche for developing an ideal pre-operative scoring system 
for predicting mortality in patients undergoing colorectal surgery. Biochemistry and 
Haematology Outcome Models (BHOM) adopt the approach of using a minimum 
dataset to model outcome following colorectal cancer surgery, a concept previously 
shown to be feasible after index arterial operations.  
Methods: Predictive binary logistic regression models (a mortality and morbidity 
model) were developed on 704 patients who underwent colorectal cancer surgery 
over a six-year period in a UK district general hospital. The outcome variables 
measured were 30 day post-operative mortality, and morbidity (defined as 
major/minor leak, abscess, bleeding or obstruction). Hosmer-Lemeshow goodness of 
fit statistics and frequency tables compared the predicted versus the reported 
number of deaths. Discrimination was quantified using the c-index. 
Results: The dataset consisted of 573 elective cases and 131 non-elective 
interventional cases. The overall mean predicted risk of death was 7.79% (50 
cases). The actual number of reported deaths was also 50 (χ2 = 1.331, d.f.=4, p-
value = 0.856; no evidence of lack of fit). For the mortality model, the predictive c-
index was = 0.810. The morbidity model had less discriminative power, however, 
there was no evidence of lack of fit (χ2 = 4.198, d.f.=4, p-value = 0.380, c-index = 
0.697). 
Conclusions: The CR BHOM mortality model suggests good discrimination (c-index 
>0.8) and uses only a minimal number of variables. However, the model needs to be 
tested on independent datasets from different geographical locations. 
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Introduction 
In recent years, several prognostic scoring systems have been developed and 
validated in different geographical settings for the assessment of mortality in 
colorectal cancer surgery. They can be used as performance indicators to allow 
objective comparisons between surgeons and surgical units because they adjust for 
patient-related risk factors and operative severity (case mix).  
The Physiology and Operative Severity Score for enUmeration of Mortality and 
morbidity (POSSUM) and Portsmouth POSSUM (P-POSSUM) were originally 
developed to predict the outcomes of general surgical patients 1, 2. A major drawback 
of the POSSUM methodology is that it requires the collection of 12 pre-operative 
physiological variables and 6 operative variables, which is time consuming and 
precludes the opportunity to obtain a purely pre-operative risk assessment.  
The Biochemistry and Haematology Outcome Model (BHOM) adopts a different 
approach; it uses a minimal data set to model outcome and has previously been 
shown to be effective with index arterial operations (vascular or VBHOM) 3-6. VBHOM 
is based on a minimal dataset derived from National Vascular Database - 
haematology and biochemistry data items, which can all be obtained pre-operatively. 
They are easy to collect from hospital pathology and patient administration computer 
systems and they are collected routinely during normal clinical care, hence data 
collection is not an additional burden.   
The aim of this study was to develop a new BHOM equation (Colorectal- or CR-
BHOM) using only a minimum number of variables to predict post-operative 
outcomes for patients undergoing colorectal cancer resection.   
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Methods & Patients 
The modelling was performed using data from a single, medium-sized (600 bed) 
district general hospital in the United Kingdom.  The unit manages about 150 new 
patients with colorectal cancer each year.  A database is maintained by a team of 
colorectal nurse practitioners and a dedicated data clerk.  The database is based 
upon the Association of Coloproctology’s (ACP) minimum dataset as specified for 
version 2.0 of the ACPGBI colorectal cancer database 
(www.nbocap.org.uk/datasets).  Every patient is entered prospectively and the 
record is regularly updated during follow-up.  Data are submitted annually to the 
Association of Coloproctology of Great Britain & Ireland for comparative audit.  
Consecutive patients undergoing elective or emergency colorectal resection entered 
into the database from its inception in mid 2001 until September 2007 were used as 
the study population.  Post-operative death was recorded.  Post-operative morbidity 
was recorded as the occurrence of any of the pre-defined complications (major or 
minor leak, abscess, bleeding or obstruction-table 1). 
The following data items were extracted from the database: discharge status of 
patient, admission date and discharge date, age at admission, mode of admission, 
gender, haemoglobin, white cell count, urea, creatinine, albumin, sodium and 
potassium levels. These blood tests were taken on admission or immediately before 
surgery. The cases were then ordered by dead/alive status at 30 days and age at 
admission. Binary logistic regression was performed on this data to form a model of 
adverse clinical outcome (30-day mortality and complication).  
It is important to have an adequate number of events (deaths or complications) in 
each set to model outcome using logistic regression. As a rule, at least ten outcome 
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events per potential predictor variable are required to minimise the risk of a Type I 
error 7.        
 
Statistical Analysis 
Within the logistic regression model mode-of-admission was modelled as follows: 1 = 
elective and 0 = non-elective. The outcome variable, mortality, was defined as death 
within 30 days post-surgery and the outcome variable, morbidity, was defined as any 
ACP-defined complication. The overall performance of the model was assessed 
using techniques designed to test both calibration and discrimination. The Hosmer-
Lemeshow 8-11 methodology was followed to assess the calibration of the model. 
Calibration refers to the agreement between predicted probabilities and true 
probabilities (goodness-of-fit). Naturally, the true probability of a patient’s outcome is 
not known; otherwise there would be no use to developing these prognostic models. 
However, true probabilities can be approximated by taking the mean of the observed 
outcomes within predefined groups of patients. This involves the use of the chi-
squared test to compare frequency tables obtained from prospective application of 
the equations. This is a null hypothesis test. A p-value <0.05 indicates a significant 
lack of fit. While it is possible to say that a model is wrong i.e. did not predict 
outcome, it is not possible to state that a particular model is correct, only that it 
performed adequately. 
Discrimination refers to a model’s ability to distinguish survivors from non-survivors. 
The discriminative ability of the model was assessed using the c-index (equivalent to 
the area under the receiver-operator characteristic (ROC) curve. Discrimination is 
the ability of the model to appropriately rank patients in terms of risk – that is, the 
model’s ability to ascribe high risks to high-risk patients and vice-versa. Values of 0.5 
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indicate that the model does not predict better than chance. It is generally accepted 
that reasonable models produce values in the range of 0.7 to 0.8 and good models 
give values 0.8 to 0.9. Forward stepwise regression was performed by adding each 
variable in turn (age, gender, mode-of-admission, sodium, potassium, urea, 
creatinine, white cell count, haemoglobin and albumin) and excluding variables with 
a p-value >0.10. The models were derived using the statistical programming 
language R version 2.5.1 (The R Foundation for Statistical Computing, Vienna, 
Austria) using the Design package (version 2.1-1). 
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Results 
The basic characteristics of the study population are summarised in tables 2-4. The 
data used contained 704 complete records. Binary logistic regression analysis of the 
laboratory and administrative data of the training set produced the outcome models 
for colorectal resection for cancer.   
Mortality models  
It was found that the mortality model could successfully predict colorectal cancer 
mortality (Table 5). The outcome of the logistic regression model for prediction of 
mortality, i.e. death within 30 days, was as follows (based on n= 704 cases): 
lne{R/(1 – R)} =   6.63 + (-1.3458 × mode of admission)  
+ (0.0285 × age on admission) + (0.1057 × urea {mmol/l})  
+ (-0.0646 × sodium {mmol/l}) + (-0.0613 × (albumin) {µmol/l}))  
 
A total of 50 patients within the dataset died within 30 days of surgery. The model 
suggested good discrimination: c-index = 0.811. 
Morbidity models  
The outcome of the logistic regression model for the prediction of morbidity was as 
follows (based on n=704 cases): 
lne{R/(1 – R)} =   6.51 + (-1.0131 × mode of admission)  
+ (0.0080 × age on admission) + (0.0841 × urea {mmol/l})  
+ (-0.0538 × sodium {mmol/l}) + (-0.0410 × (albumin) {µmol/l}))  
 
A total of 80 patients within the dataset had a complication post surgery. The models 
discrimination (c-index) was 0.697 (table 6).
9 
 
Discussion 
A scoring system capable of reliable, reproducible predictions of post-operative 
outcomes from minimal data would be a useful tool in surgical practice.  It would 
allow clinicians the opportunity of tailoring informed consent to individuals and aid 
the prioritisation of critical-care resource allocation.  Colorectal cancer is a common 
condition and when dealing with large volumes of patients, data collection can 
become a burden to busy clinicians. We have derived a ‘data economic’ model to 
predict post operative morbidity and mortality in patients undergoing colorectal 
cancer resection. The CR-BHOM is derived from variables obtained during routine 
preoperative work-up with no additional data collection requirements. This has 
distinct advantages over the existing scoring systems that are already established 
within surgical practice. 
For instance, POSSUM and P-POSSUM are scoring systems that have been 
extensively validated across different geographical locations but are recognised to 
have limitations in application to patients undergoing colorectal surgery 12-16. The 
concern that POSSUM and P-POSSUM over-predicted mortality in colorectal 
surgical patients led to the development of a specialty-specific POSSUM score 
called colorectal-POSSUM 13. This used fewer physiological variables in its 
calculation, only 6 instead of 12, and 4 operative measurements. In comparison, CR-
POSSUM was found to be a more accurate predictor of post-operative mortality in 
patients undergoing colorectal resection 17.   Despite the reduced data requirements 
for CR-POSSUM, there remains an issue regarding the subjective nature of the 
variables used. For example, the degree of peritoneal soiling (major / minor) may be 
perceived differently by different observers.  
10 
 
The Association of Coloproctology of Great Britain and Ireland (ACPGBI) model 18 is 
open to the same criticism. This scoring system assesses five operative variables; 
age, grade, Dukes stage and operative urgency and relies heavily on the fifth, the 
American Society of Anesthesiologists (ASA) grade, which is also subjective in 
nature. 
CR-BHOM, in comparison, is derived from data that is entirely objective, measured 
independently in laboratories adhering to a nationally agreed standard.  It differs 
from earlier models, vascular-BHOM 3 and amputation-BHOM, 6 with the inclusion of 
albumin as a predictor. Serum albumin concentration is a more sensitive indicator of 
surgical outcome than many other pre-operative patient characteristics 19. 
Hypoalbuminaemia has long been recognised to reflect malnutrition and disease, 
and more recently to be an independent risk factor for developing post-operative 
complications following rectal cancer surgery 20.  It is thought that ‘cancer cachexia’ 
results in altered metabolism and impairment of hepatic protein synthesis, a process 
mediated by tumour necrosis factor alpha 21. Low protein levels and thus reduced 
collagen synthesis at the site of surgical wounds and at bowel anastomoses could 
account for the higher rate of wound infections and anastomotic leakage seen. 
Serum albumin levels are also affected by trauma and surgical stress. Consequently, 
scoring systems that quantify pre-operative risk and surgical stress may be more 
useful than albumin levels alone. The Estimation of Physiological Ability and Surgical 
Stress (E-PASS) score 22 reflects how the interaction between the patient’s 
physiological reserve and surgical stress inflicted at operation can impact upon the 
likelihood of post-operative complications.  CR-BHOM does not take into account 
operative variables and thus factors such as faecal contamination and excessive 
intra-operative blood loss which will impact on post-operative outcome are not 
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considered 23. These factors could be considered iatrogenic and therefore should be 
excluded from a pre-operative risk model. 
Post operative morbidity was not predicted as accurately as post-operative mortality 
by CR-BHOM. One of the reasons for this may lie in the variability and subjective 
nature of reporting postoperative complications. Other limitations of our model are 
not specific to CR-BHOM. Geographical variation resulting in diversity of case mix 
between different centres will impact upon the reproducibility of model outcomes.  
CR-BHOM needs to be validated and probably refined in many centres at different 
geographical locations and compared against existing scoring systems (CR-
POSSUM).  As the principles of clinical governance and revalidation become more 
important, simple scoring systems become more attractive. If reproducibility can be 
proven across a range of centres, CR-BHOM will provide a truly objective tool for 
comparative audit. Extrapolation to other conditions may then also be considered. 
 
 
 
Conclusions 
CR-BHOM shows good discrimination for the prediction of post-operative mortality 
following colorectal surgery. With the inclusion of pre-operative albumin levels in the 
equation, CR-BHOM can provide more accurate and more useful information with 
regards to post-operative outcomes. The main advantage of being a data economic 
model eases its utilisation by surgeons in the pre-operative decision making process. 
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Table 1: Definition of major complications  
 Major   
 
Leak Clinical evidence of anastomotic breakdown with or 
without radiological confirmation 
 
 
Abscess 
 
 
Wound, intra abdominal or pelvic pus 
 
Post-op bleeding Gastrointestinal, intra abdominal or wound bleeding  
 
Bowel obstruction 
 
Postoperative bowel obstruction 
 
 
Major complication: a complication that required re-operation, interventional 
radiology, ITU/HDU care or delays discharge by >72 hours 
 
 
 
 
Table 2: Patient Demographics  
Variable Number Included in 
model 
Median age (years)  74, (range 28-98) Y 
Male  55.4 % Y 
Mean Haemoglobin (g/dl) 12.5 (±2.1) Y 
Mean White Cell Count (109/l) 8.9 (±3.3) Y 
Mean serum Sodium (mmol/l)  138.1 (±3.9) Y 
Mean serum Potassium (mmol/l) 4.3 (±0.5) Y 
Mean serum Urea (mmol/l) 6.2 (±3) Y 
Mean serum Albumin (µmol/l) 39.6 (±6.3) Y 
Mean serum Creatinine (µmol/l) 89.2 (±28.6) Y 
Emergency admission  18.6% Y 
Median ASA Score (range) 2 (1-4) N 
Observed in hospital mortality 7.1% N 
Observed in hospital morbidity  11.4% N 
 
Total (n = 704), normally distributed values quoted as mean (±stdev) 
 
 
 
 
 
 
 
Table 3: Specifications of tumour 
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Operation site No. of Patients     
      
Right colon 
 
280     
Left colon 
 
173     
Rectum  251     
      
      
 
 
 
Table 4:   Length of Stay 
Hospital stay 
(days) 
Number of 
patients      
      
0-5 16     
6 to 10 259     
11 to 20 286     
21 to 30 
>30 
56 
43 
    
      
      
Seven patients died within 30 days of surgery but after discharge from hospital.  
 
 
 
Table 5: Mortality - Prospective application of the new CR-BHOM Model  
Predicted 
Mortality (%) 
No. of 
Patients 
Mean 
Predicted 
Risk (%) 
Predicted 
Deaths 
Reported 
Deaths Χ
2
 
      
>0 to <7 525 3.01 16 19 0.658 
>7 to <12 68 9.01 6 5 0.228 
>12 to <33 86 19.05 16 14 0.429 
>33 to <100 25 46.74 12 12 0.016 
      
>0 to <100 704 7.79 50 50 1.331 
      
BHOM model, χ2 = 1.331, d.f.=4, p-value = 0.856; no evidence of lack of fit, c-index = 
0.81  
 
 
 
 
 
Table 6: Morbidity - Prospective application of the new CR-BHOM Model  
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Predicted 
Morbidity 
(%) 
No. of 
Patients 
Mean 
Predicted 
Risk (%) 
Predicted 
Events 
Reported 
Events Χ
2
 
      
>0 to <7 298 5.43 16 17 0.045 
>7 to <12 221 8.91 20 23 0.608 
>12 to <33 155 19.56 30 23 2.193 
>33 to <100 30 46.08 14 17 1.352 
      
>0 to <100 704 12.02 80 80 4.198 
      
 
BHOM model, χ2 = 4.198, d.f.=4, p-value = 0.380; no evidence of lack of fit, c-index = 
0.697 
 
 
 
 
 
 
 
 
 
 
 
 
